Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dry Needling and BTX-A for Poststroke Spasticity
NCT03747900Completed
- Sponsor
- Sultan Abdulhamid Han Training and Research Hospital
- Start
- Oct 2017
- Primary completion
- Mar 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, single-blind trial of botulinum toxin type A in Spasticity, sponsored by Sultan Abdulhamid Han Training and Research Hospital. Primary endpoint: Modified Ashworth Scale at 6 months. Started Oct 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT03747900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03747900.